Columbia Asset Management Eli Lilly & CO Transaction History

Columbia Asset Management

$493 Million
Q1 2024

A detailed history of Columbia Asset Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Columbia Asset Management holds 9,065 shares of LLY stock, worth $8.45 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

9,065

Previous 9,050 0.17%

Holding current value

$8.45 Million

Previous $5.28 Million 0.17%

% of portfolio

1.07%

Previous 1.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $8,883 - $11,884	15 Added 0.17%	9,065 $5.28 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $129,721 - $152,925	247 Added 2.81%	9,050 $5.28 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $445,567 - $614,282	1,025 Added 13.18%	8,803 $4.73 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.19 Million - $1.59 Million	3,389 Added 77.22%	7,778 $3.65 Million
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $29,648 - $33,787	100 Added 2.33%	4,389 $1.42 Million

Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $76,011 - $98,320	-421 Reduced 8.94%	4,289 $984,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $10,966 - $12,684	-75 Reduced 1.57%	4,710 $697,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $2,728 - $3,283	20 Added 0.42%	4,785 $786,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $2,669 - $2,904	-25 Reduced 0.52%	4,765 $533,000
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $5,083 - $5,694	-48 Reduced 0.99%	4,790 $554,000
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $4,121 - $5,150	48 Added 1.0%	4,838 $519,000
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $20,778 - $24,528	-280 Reduced 5.52%	4,790 $371,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $390,744 - $433,687	5,070	5,070 $434,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Eli Lilly & CO Transaction History